UPDATED Apr 22, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$400.96 | -3.3% | 45.6% | US$3.0t | US$471.24 | PE36.1x | E12.6% | 0.7% | Software | ||
GOOGL | US$156.28 | 1.2% | 50.5% | US$2.0t | US$166.83 | PE26.3x | E11.8% | n/a | Media | ||
2330 | NT$754.00 | -4.3% | 51.4% | NT$19.6t | NT$912.98 | PE22.8x | E16.1% | 1.9% | Semiconductors | ||
NOVO B | kr.891.30 | 2.7% | 54.4% | kr.3.9t | kr.904.20 | PE47.5x | E14.8% | 1.1% | Pharmaceuticals & Biotech | ||
CRM | US$273.81 | -1.3% | 43.6% | US$265.6b | US$335.22 | PE64.2x | E18.7% | 0.6% | Software | ||
NOVN | CHF87.36 | 2.8% | -6.2% | CHF191.3b | CHF96.36 | PE24.5x | E10.2% | 3.8% | Pharmaceuticals & Biotech | ||
ADBE | US$466.89 | -2.0% | 26.3% | US$209.2b | US$617.38 | PE43.6x | E17.1% | n/a | Software | ||
ROG | CHF225.80 | 1.9% | -19.9% | CHF182.0b | CHF281.06 | PE15.7x | E8.2% | 4.3% | Pharmaceuticals & Biotech | ||
AXP | US$233.00 | 6.7% | 49.2% | US$167.6b | US$220.17 | PE18.9x | E7.6% | 1.2% | Diversified Financials | ||
PDD | US$124.14 | 9.4% | 92.2% | US$164.9b | US$179.84 | PE19.9x | E23.0% | n/a | Retail | ||
AIR | €161.44 | 1.5% | 28.2% | €127.1b | €175.62 | PE33.6x | E17.7% | 1.1% | Capital Goods | ||
VRTX | US$399.92 | 1.5% | 20.5% | US$103.4b | US$460.34 | PE28.6x | E11.5% | n/a | Pharmaceuticals & Biotech | ||
SAF | €205.30 | 0.1% | 44.5% | €84.9b | €206.26 | PE24.7x | E5.8% | 1.1% | Capital Goods | ||
CSL | AU$278.97 | 1.6% | -8.3% | AU$134.8b | AU$308.96 | PE35.2x | E14.7% | 1.3% | Pharmaceuticals & Biotech | ||
CFR | CHF127.20 | -0.6% | -15.4% | CHF74.8b | CHF146.09 | PE19.3x | E7.8% | 2.7% | Consumer Durables | ||
SLB | US$49.51 | -3.7% | 1.1% | US$70.8b | US$67.27 | PE16.3x | E13.4% | 2.2% | Energy | ||
CRWD | US$289.15 | -3.3% | 136.7% | US$69.9b | US$390.62 | PE782.9x | E34.4% | n/a | Software | ||
1299 | HK$48.75 | 6.0% | -41.1% | HK$545.9b | HK$94.97 | PE18.5x | E17.9% | 3.3% | Insurance | ||
NTES | US$94.88 | 4.9% | 12.2% | US$59.3b | US$133.02 | PE14.6x | E7.9% | 2.7% | Media | ||
BBRI | Rp5,300.00 | -0.9% | 7.1% | Rp799.2t | Rp6,681.54 | PB2.6x | E11.3% | 6.0% | Banks | ||
300760 | CN¥284.50 | 6.2% | -6.0% | CN¥344.1b | CN¥396.59 | PE30.3x | E15.0% | 3.0% | Healthcare | ||
2454 | NT$972.00 | -7.9% | 49.5% | NT$1.5t | NT$1,200.95 | PE20.1x | E14.0% | 6.3% | Semiconductors | ||
DDOG | US$122.07 | -3.8% | 94.7% | US$40.8b | US$147.68 | PE840x | E29.2% | n/a | Software | ||
ALC | CHF73.20 | 0.4% | 13.2% | CHF36.1b | CHF84.95 | PE40.6x | E10.5% | 0.3% | Healthcare |